SPINAL MUSCULAR ATROPHY (SMA ) SMN1 GENE DELETION

image not found

NABL Cap Accredited    
This test identifies deletions in the SMN1 gene, the primary genetic cause of Spinal Muscular Atrophy (SMA), a disorder affecting muscle strength and motor neuron function. Detecting SMN1 gene deletion helps confirm the diagnosis in symptomatic individuals and supports carrier screening in families. The test provides vital information for early intervention, treatment planning, and genetic counseling. Metropolis Healthcare performs this analysis using advanced molecular techniques for high accuracy and reliability

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,360.00

Sample Type: Chorionic Villi , EDTA Blood

Fasting Not Required


Notes: S1039_C

Frequently Asked Questions (FAQ's):

What does the SMN1 gene deletion test detect?
It identifies deletions in the SMN1 gene linked to Spinal Muscular Atrophy.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses specialized molecular assays to accurately detect SMN1 gene copy number variations.

Who should undergo this test?
Individuals with muscle weakness, reduced motor milestones, or those with a family history of SMA.

Is this test useful for carrier screening?
Yes, it helps determine SMA carrier status, especially for couples planning a family.

What sample is required for the test?
A blood sample is used for genetic analysis.

Does this test confirm SMA diagnosis?
Yes, SMN1 gene deletion is the primary diagnostic indicator of SMA.

Can the test help in treatment planning?
Yes, early detection guides timely medical intervention and genetic counseling.

Does Metropolis Healthcare offer genetic counseling for SMA?
Metropolis Healthcare provides support and guidance alongside testing to help families understand results and next steps

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab